Literature DB >> 11059994

Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study.

G Lewis1, A S David, A Malmberg, P Allebeck.   

Abstract

BACKGROUND: Those with schizophrenia often give a history of premorbid non-psychotic psychiatric disorder. AIMS: To investigate the association between non-psychotic psychiatric disorders and the later development of schizophrenia.
METHOD: Men aged 18 or 19 years, conscripted to the Swedish army in 1970 (n=50 054) were linked to the Swedish National Psychiatric Case Register.
RESULTS: There was an increased risk of schizophrenia in those with ICD-8 diagnoses of neurosis (OR=4.6,95% Cl 3.2-6.9), personality disorder (OR=8.2, 95% Cl 5.4-12.3), alcohol abuse (OR=5.5, 95% Cl 1.7-17.5) or substance abuse (OR=14.0, 95% Cl 7.8-25.0) at age 18. Of those who developed schizophrenia, 38% (95% Cl 32-45) received a diagnosis of non-psychotic psychiatric disorder at age 18. Only those with personality disorder had a significantly increased risk of schizophrenia (OR=2.4, 95% Cl 1.1-5.2) with onset after age 23.
CONCLUSIONS: Personality factors could represent an underlying vulnerability to schizophrenia. Other diagnoses occurring before schizophrenia may reflect a prodromal phase of the illness.

Entities:  

Mesh:

Year:  2000        PMID: 11059994     DOI: 10.1192/bjp.177.5.416

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.

Authors:  Stanley Zammit; Peter Allebeck; Sven Andreasson; Ingvar Lundberg; Glyn Lewis
Journal:  BMJ       Date:  2002-11-23

2.  Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?

Authors:  Stephen M Lawrie; Bayanne Olabi; Jeremy Hall; Andrew M McIntosh
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

3.  The psychosis continuum in the general population: findings from the São Paulo Epidemiologic Catchment Area Study.

Authors:  Alexandre Andrade Loch; Yuan-Pang Wang; Wulf Rössler; Luis Fernando Tófoli; Camila Magalhães Silveira; Laura Helena Andrade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-16       Impact factor: 5.270

Review 4.  The aetiology of schizophrenia: what have the Swedish Medical Registers taught us?

Authors:  Sarah Harper; Helen Towers-Evans; James MacCabe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-06-19       Impact factor: 4.328

5.  Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.

Authors:  Christoph U Correll; Christopher W Smith; Andrea M Auther; Danielle McLaughlin; Manoj Shah; Carmel Foley; Ruth Olsen; Todd Lencz; John M Kane; Barbara A Cornblatt
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-10       Impact factor: 2.576

6.  Body mass index in young adulthood and suicidal behavior up to age 59 in a cohort of Swedish men.

Authors:  Alma Sörberg; David Gunnell; Daniel Falkstedt; Peter Allebeck; Maria Åberg; Tomas Hemmingsson
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

7.  Prognosis of schizophrenia in persons with and without a history of cannabis use.

Authors:  E Manrique-Garcia; S Zammit; C Dalman; T Hemmingsson; S Andreasson; P Allebeck
Journal:  Psychol Med       Date:  2014-09       Impact factor: 7.723

8.  Association of Primary Care Consultation Patterns With Early Signs and Symptoms of Psychosis.

Authors:  Sarah A Sullivan; William Hamilton; Kate Tilling; Theresa Redaniel; Paul Moran; Glyn Lewis
Journal:  JAMA Netw Open       Date:  2018-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.